Compass Therapeutics, Inc. (CMPX)
0.993
+0.01
(+0.98%)
USD |
NASDAQ |
Oct 09, 16:00
0.9912
0.00 (0.00%)
After-Hours: 20:00
Compass Therapeutics Free Cash Flow : -56.38M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -56.38M |
| March 31, 2026 | -53.29M |
| December 31, 2025 | -49.17M |
| September 30, 2025 | -45.08M |
| June 30, 2025 | -45.32M |
| March 31, 2025 | -44.24M |
| December 31, 2024 | -44.90M |
| September 30, 2024 | -48.10M |
| June 30, 2024 | -42.94M |
| March 31, 2024 | -42.31M |
| December 31, 2023 | -40.65M |
| September 30, 2023 | -38.98M |
| June 30, 2023 | -44.02M |
| March 31, 2023 | -38.43M |
| Date | Value |
|---|---|
| December 31, 2022 | -34.34M |
| September 30, 2022 | -29.08M |
| June 30, 2022 | -21.94M |
| March 31, 2022 | -23.96M |
| December 31, 2021 | -21.55M |
| September 30, 2021 | -22.77M |
| June 30, 2021 | -26.12M |
| March 31, 2021 | -24.87M |
| December 31, 2020 | -26.91M |
| September 30, 2020 | -26.03M |
| June 30, 2020 | -25.58M |
| March 31, 2020 | -29.18M |
| December 31, 2019 | -32.21M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Viking Therapeutics, Inc. | -418.44M |
| Capricor Therapeutics, Inc. | -129.78M |
| Ardelyx, Inc. | -17.92M |
| Biomea Fusion, Inc. | -47.06M |
| ARS Pharmaceuticals, Inc. | -196.60M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.74M |
| Cash from Investing (Quarterly) | -4.977M |
| Free Cash Flow Per Share (Quarterly) | -0.0798 |
| Free Cash Flow to Equity (Quarterly) | -14.76M |
| Free Cash Flow to Firm (Quarterly) | -14.91M |
| Free Cash Flow Yield | -31.24% |